Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study

References

• PrioriSGBlomström-LundqvistCMazzantiA2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)Eur Heart J201536412793286726320108
   PubMed Web of Science ®Google Scholar
• APA-OTSÄrztekammer: Höhere Überlebensraten bei Herzstillstand sind machbar [Austrian Medical Chamber: higher survival rates in cardiac arrest patients are feasible]2013 Available from: http://www.ots.at/presseaussendung/OTS_20131015_OTS0124/aerztekammer-hoehere-ueberlebensraten-bei-herzstillstand-sind-machbarAccessed September 29, 2016 German
   Google Scholar
• MozaffarianDBenjaminEJGoASAmerican Heart Association Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics—2015 update: a report from the American Heart AssociationCirculation20151314e29e32225520374
   PubMed Web of Science ®Google Scholar
• MyerburgRJJuntillaMJSudden cardiac death caused by coronary heart diseaseCirculation201212581043105222371442
   PubMed Web of Science ®Google Scholar
• Haute Autorité de SantéLifeVest 4000St DenisHaute Autorité de Santé2014
   Google Scholar
• BlueCross Blue Shield Association (BCBSA) Technology Evaluation Center (TEC)Wearable Cardioverter-Defibrillator as a Bridge to Implantable Cardioverter-Defibrillator TreatmentChicago, ILBlue Cross Blue Shield Association (BCBSA)2010
   Google Scholar
• PicciniJPSrAllenLAKudenchukPJPageRLPatelMRTurakhiaMPAmerican Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology and Council on Cardiovascular and Stroke NursingWearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death: a science advisory from the American Heart AssociationCirculation2016133171715172727022063
   PubMed Web of Science ®Google Scholar
• ReekSBurriHRobertsPREHRA Scientific Documents Committee (as external reviewers)The wearable cardioverter-defibrillator: current technology and evolving indicationsEuropace201719333534527702851
   PubMed Web of Science ®Google Scholar
• MogaCGuoBSchopflocherDHarstallCDevelopment of a Quality Appraisal Tool for Case Series Studies Using a Modified Delphi TechniqueEdmonton, ABInstitute of Health Economics2012
   Google Scholar
• KleinHUGoldenbergIMossAJRisk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillatorEur Heart J201334292230224223729691
   PubMed Web of Science ®Google Scholar
• European Network for Health Technology Assessment (EUnetHTA)Endpoints used in relative effectiveness assessment: surrogate endpoints2015 Available from: http://www.eunethta.eu/outputs/endpoints-used-relative-effectiveness-assessment-surrogate-endpoints-amended-ja1-guideline-fAccessed June 6, 2016
   Google Scholar
• European Network for Health Technology Assessment (EUnetHTA)EUnetHTA guidelines2015 Available from: http://www.eunethta.eu/eunethta-guidelinesAccessed June 6, 2016
   Google Scholar
• BalshemHHelfandMSchünemannHJGRADE guidelines: 3. Rating the quality of evidenceJ Clin Epidemiol201164440140621208779
   PubMed Web of Science ®Google Scholar
• EttingerSStanakMHuicMWearable cardioverter-defibrillator therapy in primary and secondary prevention of sudden cardiac arrest in patients at riskRapid assessment on other health technologies using the HTA Core Model for Rapid Relative Effectiveness AssessmentEUnetHTA Project ID: OTCA012016 Available from: http://www.eunethta.eu/outputs/1st-collaborative-assessment-wearable-cardioverter-defibrillator-wcd-therapy-primary-and-secAccessed January 31, 2017
   Google Scholar
• European Network for Health Technology Assessment (EUnetHTA)Rapid relative effectiveness assessments (4.2)2016 Available from: http://meka.thl.fi/htacore/ViewApplication.aspx?id=25468Accessed June 6, 2016
   Google Scholar
• European Network for Health Technology Assessment (EUnetHTA)HTA Core Model2016 Available from: http://meka.thl.fi/htacore/BrowseModel.aspxAccessed June 6, 2016
   Google Scholar
• HigginsJPTGreenSCochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [Updated March 2011]LondonThe Cochrane Collaboration2011
   Google Scholar
• DurandMAChantlerTPrinciples of Social ResearchLondonOpen University Press2014
   Google Scholar
• FriedAWildCBeteiligung von BürgerInnen und PatientInnen in HTA Prozessen. Internationale Erfahrungen und Good Practice Beispiele [Participation of Citizens and Patients in HTA Processes. International Experience and Good Practice Examples]WienLudwig Boltzmann Institut für Health Technology Assessment2016 German
   Google Scholar
• FeldmanAMKleinHTchouPWEARIT investigators and coordinatorsBIROAD investigators and coordinatorsUse of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD.[Erratum appears in Pacing Clin Electrophysiol. 2004 May;27(5):following table of contents]Pacing Clin Electrophysiol20042714914720148
   PubMed Web of Science ®Google Scholar
• DunckerDHaghikiaAKönigTRisk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillatorEur J Heart Fail201416121331133625371320
   PubMed Web of Science ®Google Scholar
• KondoYLinhartMAndriéRPSchwabJOUsefulness of the wearable cardioverter defibrillator in patients in the early post-myocardial infarction phase with high risk of sudden cardiac death: a single-center European experienceJ Arrhythm201531529329526550085
   PubMedGoogle Scholar
• KaoACKrauseSWHandaRWearable defibrillator use In heart Failure (WIF) InvestigatorsWearable defibrillator use in heart failure (WIF): results of a prospective registryBMC Cardiovasc Disord20121212323234574
   PubMed Web of Science ®Google Scholar
• KutyifaVMossAJKleinHUse of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry)Circulation2015132171613161926316618
   PubMed Web of Science ®Google Scholar
• ChungMKThe role of the wearable cardioverter defibrillator in clinical practiceCardiol Clin201432225327024793801
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration (FDA)FDA approves wearable defibrillator for children at risk for sudden cardiac arrest2015 Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm466852.htmAccessed April 14, 2016
   Google Scholar
• AdlerAHalkinAViskinSWearable cardioverter-defibrillatorsCirculation2013127785486023429896
   PubMed Web of Science ®Google Scholar
• GanzLIGeneral principles of the implantable cardioverter-defibrillatorUptodate2016 Available from: http://www.uptodate.com/contents/general-principles-of-the-implantable-cardioverter-defibrillatorAccessed October 5, 2016
   Google Scholar
• GarnerAMAnejaSJahan-TighRRAllergic dermatitis from a defibrillator vestDermatitis2016273151
   Web of Science ®Google Scholar
• CroninEMBiancoNRChungRAbstract 14183: some like it cool-seasonal temperature, as well as clinical and demographic factors, predicts compliance with the wearable cardioverter defibrillatorCirculation2011124Suppl 21A14183
   Google Scholar
• ChungMKWearable cardioverter-defibrillatorPageRLDowneyBCUpToDateWaltham, MAUpToDate2016
   Google Scholar
• ChungMKSzymkiewiczSJShaoMNiebauerMJLindsayBDTchouPJAggregate national experience with the wearable cardioverter-defibrillator vest: event rates, compliance and survivalJ Am Coll Cardiol20105510A10.E98
   Web of Science ®Google Scholar
• LaPageMJCanterCERheeEKA fatal device-device interaction between a wearable automated defibrillator and a unipolar ventricular pacemakerPacing Clin Electrophysiol200831791291518684292
   PubMed Web of Science ®Google Scholar
• FrancisJReekSWearable cardioverter defibrillator: a life vest till the life boat (ICD) arrivesIndian Heart J2014661687224581099
   PubMedGoogle Scholar
• GawandeAComplications: A Surgeon’s Notes on a Imperfect ScienceNew YorkPicador2002
   Google Scholar
• LenarczykRPotparaTSHaugaaKHHernández-MadridASciaraffiaEDagresNScientific Initiatives Committee, European Heart Rhythm AssociationThe use of wearable cardioverter-defibrillators in Europe: results of the European Heart Rhythm Association surveyEuropace201618114615026842735
   PubMed Web of Science ®Google Scholar
• KetilsdottirAAlbertsdottirHRAkadottirSHGunnarsdottirTJJonsdottirHThe experience of sudden cardiac arrest: becoming reawakened to lifeEur J Cardiovasc Nurs201413542943524013168
   PubMed Web of Science ®Google Scholar
• La PageMJSaltzmanGMSchumacherKRCost effectiveness of the wearable automated defibrillator for primary prevention in pediatric heart transplant candidatesJ Card Fail2013198S64
   Web of Science ®Google Scholar
• KondoYKuritaTUedaMEfficacy and cost-effectiveness of wearable cardioverter-defibrillator as a lifesaving-bridge therapy for decision in high risk Japanese patients of sudden arrhythmic deathHeart Rhythm2016135S150
   Google Scholar
• AdelsteinEVoigtASabaSWangNJainSSinghMReply: no utility of the wearable cardioverter-defibrillator in patients with nonischemic cardiomyopathy?J Am Coll Cardiol20166723280827282907
   PubMed Web of Science ®Google Scholar
• SinghMAlluriKVoigtAAbstract 12637: utility of the wearable cardioverter-defibrillator for patients with newly diagnosed non-ischemic cardiomyopathy?Circulation2014130Suppl 2A12637
   Google Scholar
• AuricchioAKleinHGellerCJReekSHeilmanMSSzymkiewiczSJClinical efficacy of the wearable cardioverter-defibrillator in acutely terminating episodes of ventricular fibrillationAm J Cardiol19988110125312569604964
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug AdministrationPremarket approval (PMA)2016 [cited August 22, 2016]. Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P010030
   Google Scholar